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Inhalation treatment with nanoparticle containing aerosols appears a promising new therapeutic option
but new formulations have to be assessed for efﬁcacy and toxicity. We evaluated the utility of a VITRO-
CELL6 PT-CF + PARI LC SPRINT Baby Nebulizer (PARI BOY) system compared with a conventional
MicroSprayer. A549 cells were cultured in the air–liquid interface, exposed to nanoparticle aerosols
and characterized by measurement of transepithelial electrical resistance and staining for tight junction
proteins. Deposition and distribution rates of polystyrene particles and of carbon nanotubes on the cells
were assessed. In addition, cytotoxicity of aerosols containing polystyrene particles was compared with
cytotoxicity of polystyrene particles in suspension tested in submersed cultures. Exposure by itself in
both exposure systems did not damage the cells. Deposition rates of aerosolized polystyrene particles
were about 700 times and that of carbon nanotubes about 4 times higher in the MicroSprayer than in
the VITROCELL6 PT-CF system. Cytotoxicity of amine-functionalized polystyrene nanoparticles was sig-
niﬁcantly higher when applied as an aerosol on cell cultured in air–liquid interface culture compared
with nanoparticle suspensions tested in submersed culture. The higher cytotoxicity of aerosolized nano-
particles underscores the importance of relevant exposure systems.
 2012 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction and alpha-1-trypsin deﬁciency compared to conventional viralInhalation is considered a suitable route for both topical and
systemic pharmaceutical applications. Asthma, chronic obstructive
pulmonary disease and pulmonary infections are targets for topic
inhalation treatment. In addition, inhalation may also be appropri-
ate to treat systemic diseases. Absorption by the lung is high since
the alveolar surface is quite large (80–140 m2; (Weibel, 1963)) and
the air–blood barrier (0.1–0.2 lm thick) is more permeable than
other epithelial barriers. No other non-invasive application route
provides the same systemic bioavailability and speed of action as
inhalation. For therapeutic gene delivery via inhalation a lower risk
of immunogenicity and toxicity has been reported in cystic ﬁbrosiseres; FBS, fetal bovine serum;
nimal essential medium; ZO-
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-NC-ND license.vectors (Roy and Vij, 2010). Macromolecules for systemic inhala-
tion treatment also include hormones, especially insulin, growth
factors, different interleukins and heparin (Siekmeier and Scheuch,
2008). Using nanoparticle-based medication, a more efﬁcient treat-
ment of inﬂammation and mucus hypersecretion in asthma,
chronic obstructive pulmonary disease and cystic ﬁbrosis is ex-
pected. Nanoparticle-based medications also offer the possibility
of increased mucus layer penetration since they can be designed
with positive charge, better mucoadhesive properties, enhancers
for drug absorption, mucolytic agents and compounds that open
epithelial tight junctions. Using these tools an increased delivery
of drugs in nanoparticle-based aerosol formulations is expected
(Mansour et al., 2009). Physiological relevant testing of aerosols
is needed to assess these nanoparticle formulations but established
in vitro systems are rare and complicated to operate. In vivo sys-
tems face problems with interspecies differences in the morphol-
ogy and physiology of the respiratory tract, with the ease of
application and low deposition rates.
The relevant biological evaluation of nanoparticle-based medi-
cation requires a physiological exposure system, and deposition
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quired for safety reasons. To assess cytotoxicity, in vitro studies are
most commonly done on cell lines rather than on primary cells be-
cause cell lines yield more reproducible results. A549 cells are still
the most commonly used cell line for cytotoxicity testing of nano-
particles (e.g., Akhtar et al., 2012; Lankoff et al., 2012; Stoehr et al.,
2011), although tightness of intercellular junctions is lower than
that of other cell lines derived from the respiratory system, such
as H358, H596, H322 cells. The later cell lines, however, are used
less often in pharmacological and toxicological testing because
they are less well characterized.
To test aerosol exposure, respiratory cells are often exposed in
submersed culture, although this does not reﬂect their normal phys-
iological situation.More advanced in vitro exposuremodels use cul-
ture in the air–liquid interface (ALI)where cells are cultured on semi
permeablemembranes of a transwell insert. The insert is placed into
a culture well, medium is supplied from the basal site only and cells
are exposed to an aerosol at the apical part. Transwell cultures were
ﬁrst used for permeability studies of gastrointestinal cells, like Caco-
2 cells, and later adapted to other cell types (Hidalgo et al., 1989).
Several systems are available to expose transwell cultures to aero-
sols: the Voisin chamber (Voisin et al., 1977; Voisin and Wallaert,
1992), the Minucell system (Bitterle et al., 2006; Tippe et al.,
2002), the Cultex system (Aufderheide and Mohr, 2000; Ritter
et al., 2003) and the modiﬁed Cultex system, the VITROCELL system
(Aufderheide and Mohr, 2004). These systems have been used for
volatile organic compounds and carbon or cerium oxide nanoparti-
cles in the atmosphere (Bakand et al., 2006; Bitterle et al., 2006; Gas-
ser et al., 2009; Paur et al., 2008; Rothen-Rutishauser et al., 2009).
For nanoparticle-containing aerosols the ALICE (air liquid interface
exposure) system (Brandenberger et al., 2010a,b; Lenz et al., 2009)
and the MicroSprayer has been used (Blank et al., 2006).
In this study, we evaluated a new test system based on the
VITROCELL system by assessing the deposition rate of nanoparti-
cle-containing aerosols in respiratory cells compared to a macro-
molecular reference substance. We were particularly interested
in the suitability of this new system when using a nebulizer type
also frequently used by patients. This VITROCELL based system
was compared to a manual aerolizer, the MicroSprayer, which al-
lows the direct application of aerosols to cells. Cellular effects ob-
served by direct application of the aerosol to cells cultured in ALI
were compared to those obtained by testing of nanoparticle sus-
pension on cells cultured in submersed culture. These data can
help to decide whether larger work and material efforts of aerosol
exposure testing are justiﬁed.
For the evaluation of the system two particle types were used.
Polystyrene particles, which can be obtained in reproducible form
in different sizes and with different surface functionalization, were
used as models for spherical particles. These particles have the
additional advantage that they also allow the determination of
the deposition rate in their core-ﬂuorescently labeled form. Mul-
ti-walled carbon nanotubes with different diameters were used
to identify the inﬂuence of shape and the aggregation behavior of
the nanoparticles since carbon nanotubes show high aggregation
and polystyrene particles low aggregation (Wiesner and Colvin,
2005). Carbon nanotubes are also candidates for numerous medical
applications (Zhang et al., 2010).2. Methods
2.1. Nanoparticles and reference substances
20, 40, 100, and 200 nm red (580/605) ﬂuorescent labeled car-
boxyl-functionalized polystyrene particles (FluoSpheres) were pur-
chased from Invitrogen (Vienna). Carboxylated short multi-walledcarbon nanotubes (0.5–2 lm long, purity >95%) with outer diame-
ters <8, 20–30 and >50 nm were obtained from CheapTubes Inc.
(Brattleboro, Vermont). To identify a potential difference in cyto-
toxicity between exposure in submersed culture and exposure as
aerosol, 20 nm amine-functionalized polystyrene particles were
used (Estapor Microspheres, Merck Chimie S.A.S., Fontenay-sous-
Bois). For exposure all nanoparticles were diluted and the suspen-
sions were put into an Elmasonic S40 water bath (ultrasonic fre-
quency: 37 kHz, Elma, Singen) for 20 min prior to all
experiments. For the VITROCELL system and the MicroSprayer cells
were cultured for 24 h after the exposures. Fluorescein sodium salt
(Sigma Aldrich, Steinheim) was used as a macromolecular refer-
ence substance.
2.2. Physico-chemical characterization by photon correlation
spectroscopy and transmission electron microscopy
Nanoparticle-sizes were determined routinely by dynamic light
scattering using a Zetasizer Nano ZS (Malvern Instruments, Mal-
vern) equipped with a 532 nm HeNe laser, taking into account vis-
cosity as well as refraction index. Polystyrene particles were
diluted with the same solvent used for the exposures (distilled
water for VITROCELL PT/PARI BOY LC Sprint system and
DMEM + 10% FBS for MicroSprayer) to a concentration of 200 lg/
ml and sonicated for 20 min before measurements. To study the
stability of the nanoparticles in the VITROCELL PT/PARI BOY LC
Sprint system samples of the condensate from the vial at the end
of the glass tube (Fig. 1a) were also tested. After equilibration of
the sample solution to 25 C, scattered light was detected at a
173 angle with laser attenuation and the dynamic ﬂuctuations
of light scattering intensity caused by Brownian motion of the par-
ticles was evaluated. Polydispersity Indices <0.2 are interpreted as
indication for homogenous samples (Stancampiano et al., 2008).
The viscosities of the different solutions were 0.88 cP (water)
and 0.94 cP (DMEM + 10% FBS). Additionally, the refraction indices
of all investigated media were found to be around 1.33 (1.33 for
water, 1.345 DMEM + 10% FBS. These values were very similar
and showed no impact on the measured particle sizes.
CNTs were suspended in DMEM + 10% FBS at 1 mg/ml. Prior to
sizing, the solution was put through another sonication cycle for
dispersion and diluted to 1 lg/ml for measurement in the ZetaSiz-
er. NNLS software was used for sample analysis.
The zeta potential was measured by Laser Doppler Velocimetry
(LDV) coupled with Photon Correlation Spectroscopy using a Zeta-
sizer Nano ZS (Malvern Instruments, Malvern). The experiments
were conducted at 25 C and a scattering angle of 17. The Zetapo-
tential was calculated out of the electrophoretic mobility by apply-
ing the Henry equation.
Although Photon Correlation Spectroscopy has its limitations
for the assessment of ﬁbrous particles it is an accepted technique
to describe physicochemical parameters of CNTs in solvents (Ito
et al., 2004; Lee et al., 2005). Hence, this method has also been used
by several other groups for the characterization of CNTs for biolog-
ical experiments (e.g., (Bhirde et al., 2010; Wang et al., 2011; Yang
et al., 2012)). To verify this data by another independent method,
CNTs were also characterized by transmission electron microscopy.
The CNTs were dispersed in DMEM + 10% FBS at 1 mg/ml and trea-
ted with ultrasound for 20 min. Five Microlitre of this solution
were placed on a carbon coated copper grid that had previously
been treated with a Pelco EasyGlow glow discharge device (Ted
Pella, Inc., Redding, CA). After 1 min incubation, the solution was
withdrawn using non hardened microscopic ﬁlter paper (What-
man, VWR International). Images were taken using a FEI Tecnai
G2 20 transmission electron microscope (FEI Eindhoven) with a Ga-
tan ultrascan 1000 ccd camera. Acceleration voltage was 80 kV.
Sizes of CNTs were measured from the TEM images.
Fig. 1. Exposure systems. (a): The main compounds of the VITROCELL6 PT/PARI BOY exposure system are indicated: PARI BOY SX compressor connected by tubes to the
PARI BOY LC SPRINT Baby nebulizer produces the aerosol. The ﬂow of the aerosol from the nebulizer via a glass tube to the three individual compartments of the exposure
module until the collection of aerosol not delivered to the compartments in a plastic vial is indicated. Airﬂow is regulated by a vacuum pump (not seen) that aspirates air from
each of the three compartments of the exposure module through plastic tubes. For temperature maintenance at 37 C a water bath connected to the exposure unit by plastic
tubing, is used. (b): The tube of the MicroSprayer IA-1C aerosolizer is attached with a clamp to a tripod and the position of the tip is ﬁxated at a distance of 11 cm from the rim
of the exposure well. The long ﬂexible tube allows the activation of the syringe to generate the aerosol without displacing the aerosolizer tip.
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A549 human lung adenocarcinoma cells (ATCC) were cultured
in DMEM + 10% fetal bovine serum in 6-well multiwell plates with
polycarbonate membrane transwells (ThinCerts, Greiner bio-one,
Frickenhausen). Cells were seeded with 500,000 cells/well. Cells
in transwells were cultured in both liquid, submersed culture
(LCC, cell culture medium in apical and basal compartment) and
air–liquid interface (ALI) (apical compartment air and basal com-
partment cell culture medium) at 37 C in a 95% air/5% CO2 atmo-
sphere. For the exposures in the VITROCELL/PARI BOY and in the
MicroSprayer, cells were seeded, medium was removed after
24 h and cells were cultured for an additional 7–8 days prior to
the exposures.
2.4. Immunocytochemistry
2.4.1. Staining of tight junction proteins
The expression of tight junction proteins in cells was studied by
the immunocytochemical localization of zona occludens protein-1
(ZO-1) and claudin-1. E-cadherin was chosen as a representative
protein that is present in adherent junctions.
Cells were ﬁxed by incubation in 100% ethanol for 20 min, in
100% methanol for 2.5 min and in 1:1 ethanol/acetone 10 min at
20 C. Thereafter, ﬁrst antibodies and negative controls were
added for 30 min at RT, followed by incubation with the secondary
antibodies for 30 min at RT and counterstained with Hoechst
33342 for 15 min. Between all incubations, cells were rinsed three
times for 5 min in PBS. The following antibodies and dilutions were
used: ZO-1 (rabbit polyclonal antibody, 1:100, Invitrogen), Clau-
din-1 (mouse monoclonal antibody, 1:40, Invitrogen), E-Cadherin
(mouse monoclonal antibody, 1:100, Biozym, Vienna), AlexaFlu-
or546 labeled anti-mouse IgG (goat polyclonal antibody, 1:200
Invitrogen), AlexaFluor488 labeled anti-rabbit (goat polyclonal
antibody, 1:400 Invitrogen), negative controls (rabbit IgG and
mouse IgG, Linaris, Bellingen). Cells were mounted in ﬂuorescence
mounting medium and viewed at a LSM 510 Meta Laser Scan
microscope (Zeiss, Vienna) with the following settings: 488 nm
excitation wavelength using a BP 505–530 nm band-pass detection
ﬁlter for AlexaFluor488 and 543 nm excitation wavelength in con-
junction with a LP 560 nm long pass ﬁlter for the red channel
(AlexaFluor546).
2.4.2. Cytoskeleton staining (Actin)
After exposure, cells were rinsed in PBS, ﬁxed in 3.7% parafor-
maldehyde for 10 min at RT and washed (3  5 min) in PBS. Cells
were permeabilized by incubation in acetone for 3 min at 20 Cand rinsed again. Cells were stained with 165 nM phalloidin Alexa-
Fluor 488 (Invitrogen, 1:40 dilution of stock solution in methanol)
for 20 min at RT in the dark, rinsed in PBS, counterstained by
immersion in 1 lg/ml Hoechst 33342 (Invitrogen) in PBS for
10 min, rinsed again in PBS and mounted in ﬂuorescence medium.
Pictures were taken using a LSM 510 Meta with 488 nm excitation
wavelength using a BP 505–530 nm band-pass detection ﬁlter.
2.5. Transepithelial electrical resistance (TEER)
The formation of tight junctions indicating healthy cell mono-
layers was studied by measuring the transepithelial electrical
resistance. To follow the development of TEER cells were cultured
for up to 18 days. 2 ml DMEM were added to the apical and 3 ml
DMEM were added to the basal compartment for TEER measure-
ment with a EVOM STX-2-electrode (World Precision Instruments,
Berlin). Calculation of TEER:
TEER ðX  cm2Þ ¼ Sample bank resistance ðTranswell without cellsÞ Membrane area2.6. Quantiﬁcation of deposition and distribution rate
For deposition and distribution studies, solutions of 2 mg/ml
and 200 lg/ml FluoSpheres (VITROCELL/PARI BOY) and 1 mg/ml
(MicroSprayer) were aerosolized. A549 cells in transwells were ex-
posed to these solutions for 1 h in the VITROCELL/PARI BOY or up
to three doses in the MicroSprayer and cultured for additional 24 h.
To quantify deposition and distribution rates, cells were lysed
by adding 10 ll of lysis solution (one part 70% ethanol + one part
Triton X100 to 500 ll distilled water) for 10 min at 37 C. Fluores-
cence was read at a FLUOstar optima (BMG) at 485/520 nm for
ﬂuorescein and at 584/612 nm for red FluoSpheres. Calculation of
deposition:
Deposition ð%Þ ¼ Signal sample dilution
Signal ðnebulized solutionÞ  dilution volume nebulized 100
To take into account a potential inﬂuence of the cell lysate, 10 ll
cell lysate of non-exposed cells was also added to the stem solution
sample used for aerosolization for the measurement. For the depo-
sition of CNTs absorbance of the lysates was read at 360 nm using a
SPECTRA MAX plus 384 photometer (Molecular Devices).
To test for differences between the three compartments in the
VITROCELL/PARI BOY exposure unit the distribution rate was cal-
culated according to the equation:
Distribution ð%Þ ¼ Signal ðsignal compartmentÞ
Signal ðall compartmentsÞ  100
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As an indication for healthy monolayers of A549 cells, viability
according to formazan bioreduction (MTS) was used. Formazan
bioreduction by cellular dehydrogenases was assessed by CellTiter
96 Aqueous Non-Radioactive Cell Proliferation Assay (Promega,
Mannheim) using a water-soluble tetrazolium salt according to
the manufacturer’s instructions. In short, after the 24 h following
the exposure of the cells to polystyrene particles, medium was re-
moved for the submersed cultures. To all wells the combined MTS/
PMS solution (200 ll + 1 ml medium) was added. Plates were incu-
bated for 2 h at 37 C in the cell incubator. Absorbance was read at
490 nm on a plate reader (SPECTRA MAX plus 384, Molecular De-
vices). To correct for absorbance by the polystyrene particles alone,
the signal of MTS/PMS + particles (in the absence of cells) was sub-
tracted. All values are referred to solvent-exposed cells as 100%.
For the evaluation of CNTs the MTS assay was performed in a
slightly different protocol because pilot experiments showed that
the absorbance of CNTs interfered with the MTS signal. Therefore,
to ensure that the signal of formazan bioreduction was not inﬂu-
enced by the absorbance of CNTs, cells were washed three times
with PBS at the end of the incubation with the CNTs. Subsequently
the combined MTS/PMS solution (200 ll + 1 ml medium) was
added to the wells and after formation of the formazan product
(2 h at 37 C) the supernatant was transferred to a new plate for
the measurement.2.8. VITROCELL PT/PARI BOY LC Sprint system (Fig. 1a)
For the exposures the following parts of a commercial VITRO-
CELL System (VITROCELL Systems GmbH, Waldkirch) were used:
VITROCELL6 PT-CF stainless steel exposure unit with three com-
partments for transwell inserts of a 6-well plate. The thermostat
HAAKE C10 P5 (Thermoscientiﬁc, München) regulated the temper-
ature in the exposure block and the vacuum pump N840 FT.18
(Neuberger GmbH, Freiburg) controlled the air ﬂow through the
exposure unit. This unit was connected to a PARI BOY SX com-
pressor (Pari GmbH, Starnberg) in combination with Pari LC Sprint
Nebulizer Baby1 for generation of the aerosol. This nebulizer has an
output rate of 150 mg/min and a mass median diameter of 2.5 lm
and a mass percentage below 5 lm of 82%.
Tubings were connected according to the pre-established proto-
col provided by VITROCELL. In pilot experiments, speciﬁc parame-
ters (nebulizer type, tube types, temperature, velocity, solvent)
were varied to optimize the deposition rate. The delivery of sub-
stances to cells was higher for Pari LC SPRINT baby nebulizer than
for Pari LC SPRINT junior. The Pari LC SPRINT junior produced more
aerosol, but a high fraction of this aerosol condensed on the glass
tubes. Best deposition rates were obtained using the glass tube
and not the steel tube. Steel tubes are recommended for dry mate-
rials and, apparently, are less suited for liquids due to a higher con-
densation rate. The system worked optimally at temperature
between 21 and 25 C, without external cooling or heating of the
glass tube. All experiments were performed under a hood in an
air-conditioned room (variations between 21 and 25 C). Mass ﬂow
was varied between 1 ml/min and 10 ml/min with best deposition
rates at 5 ml/min. Deposition rates of ﬂuorescein at 1 ml/min and
at 10 ml/min were 0.19–0.36% (3rd compartment – 1st compart-
ment) and 0.38–0.42% (3rd compartment – 1st compartment) of
the deposition at 5 ml/min, respectively. Aerosolization in a variety
of solvents (distilled water, PBS, 0.9% saline, DMEM, DMEM + 2%
FBS) did not cause morphological damage to the exposed cells.1 www.pari.de/en/products/lower_airways/product/detail/info/techdata/
pari_lc_sprint_baby_nebuliser_size_2.html.As nebulization in distilled water produced the highest deposition
rates, this solvent was used for the exposures of polystyrene
particles.
2.8.1. Aerosol exposure of cells
The established system used in all experiments worked with
PariLC SPRINT baby, glass tube as inlet, at room temperature, with
a ﬂow rate of 5 ml/min and distilled water was used as solvent. For
FluoSpheres an optimal deposition rate was seen at 200 lg/ml
whereas, 50 and 500 lg/ml showed lower deposition rates. CNTs
were assessed at 50 lg/ml. Cells were exposed for 1 h and a vol-
ume of 10 ml for FluoSpheres and 8 ml for CNTs was nebulized.
2.9. MicroSprayer IA-1C exposure (Fig. 1b)
The MicroSprayer IA-1C aerosolizer (PennCentury Inc., Wynd-
moor, PA) consists of a thin, ﬂexible, stainless steel tube measuring
0.64 mm in diameter and 50.8 cm in length attached to the light,
hand-operated, high-pressure syringe FMJ-250. A unique patented
atomizer at the very tip of the tube generates the aerosol with a
mass median diameter of 16–22 lm (http://www.penncentu-
ry.com/products/IA_1C.php). The MicroSprayer was ﬁxated at a
distance of 11 cm between tip of the MicroSprayer and the rim of
the 6-well plate. This distance was determined as optimal for a
reproducible delivery of the aerosol. To deliver the aerosol in a
reproducible way the syringe was actuated in one fast push. For
safety reasons all exposures were performed in a HERAsafe KS 9
clean bench (Thermo Scientiﬁc, Vienna) equipped with UPLA ﬁlters
of both ﬁlter grades U15 and H14. Aerosols with the MicroSprayer
were generated with the same solvent as the VITROCELL/PARI BOY
system (distilled water, PBS, 0.9% saline, DMEM, DMEM + 2% FBS)
but in addition allowed aerosolization of substances in
DMEM + 10% FBS. The maximum concentration of particles, which
could be aerosolized without clogging of the aerosolizer tip and the
maximum number of spray doses, which did not result in a contin-
uous liquid layer on top of the cells, were determined.
2.9.1. Aerosol exposure of cells
Polystyrene nanoparticles (1000 lg/ml suspended in
DMEM + 10% FBS) and CNTs (500 lg/ml suspended in DMEM + 10%
FBS) were applied in three spray doses (600 ll aerosol). For the
exposures, transwells were transferred to another plate, the expo-
sure plate, and subsequently replaced and cultured for additional
24 h.
2.10. Statistical analysis
Data from three to ﬁve independent experiments (number of
experiments indicated in the ﬁgures) were subjected to statistical
analysis and are represented as means ± SD data were analyzed
with one-way analysis of variance (ANOVA) followed by Tukey-
HSD post hoc test for multiple comparisons (SPSS 19 software). Re-
sults with p-values of less than 0.05 were considered to be statis-
tically signiﬁcant.
3. Results
3.1. Physicochemical characterization of nanoparticles
The size of all polystyrene particles was increased in
DMEM + 10% FBS compared with distilled water (Table 1). The size
increase of the amine-functionalized particles was larger than that
of the carboxyl-functionalized particles and the size of smaller par-
ticles increased more than that of the larger particles. Sample het-
erogeneity for carboxyl-functionalized polystyrene particles,
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DMEM + 10% FBS than in water, indicating a greater tendency for
aggregate formation in protein-containing medium. The opposite
trends were seen for CNTs, in distilled water aggregates predomi-
nated and the polydispersity index was high, whereas in
DMEM + 10% FBS sizes were much smaller and the polydispersity
index lower. Zeta-potential values of carboxyl- functionalized
polystyrene particles were negative when suspended in distilled
water and positive for amine-functionalized ones. When sus-
pended in DMEM + 10% FBS zeta-potential values of both polysty-
rene particle types were close to neutral. Zeta-potential values of
CNTs in distilled water and in DMEM + 10% FBS were in the slightly
negative range. Transmission electron microscopical analysis
showed that all CNTs were shorter than indicated by the producer
with maximum length of 450 nm. CNT8, CNT20 and CNT50 had
diameters of 4.7 ± 0.48, 18.9 ± 0.9 and 62.8 ± 5.7 nm, respectively.
To assess the inﬂuence of nebulization on the particles, 20 and
200 nm carboxyl-functionalized polystyrene particles were also
characterized in aerosols collected at the end of the glass tube. In
addition to agglomerates predominant peaks at 46 nm for the
20 nm polystyrene particles and 234 nm for the 200 nm polysty-
rene particles were recorded, suggesting that the particles are sta-
ble in the aerosol.
3.2. Physiology and morphology of A549 cells in the exposure systems
Cells cultured in ALI had a slightly lower viability (85 ± 8%) than
those cultured in submersed culture, which may be due to a lower
hydration of cells in ALI culture. The viability of ALI cultured cells
exposed to solvent without particles from the VITROCELL PT/PARI
BOY system was 110 ± 10% of the non-exposed cells in ALI culture
and similar to cells cultured in submersed culture. Viability of cells
exposed to aerosols without nanoparticles generated by MicroS-
prayer was 112 ± 7% of the non-exposed cells in ALI culture.
TEER values were determined over two weeks to determine the
stability of the ALI culture. Values increased during the ﬁrst
13 days up to 230 ± 17.33 cm2 and subsequently decreased from
day 16 on (Fig. 2a); cells were routinely used after 7–8 days of cul-
ture. All tested proteins related to the formation of cellular junc-
tions were detected in the A549 cells (Fig. 2b). Co-localization of
ZO-1 and E-cadherin was seen at all-time points. Co-localization
of ZO-1 and claudin-1 was absent after 24 h and weak at later time
points.
3.3. Deposition and distribution rate of nanoparticles
Both, VITROCELL PT/PARI BOY and MicroSprayer system
showed a similar homogeneous deposition of nanoparticles on
the A549 monolayer (Fig. 3, VITROCELL PT/PARI BOY system
shown) but the deposition rate showed pronounced differences be-
tween the two systems (Table 2). Nanoparticle deposition rate withTable 1
Solvent-dependent changes in the physico-chemical parameters of carboxyl (CPS) and amin
two experiments of dynamic light scattering (size) and electrophoretic light scattering (su
Particles Size (nm) Polydispers
Aqua dest. DMEM, 10% FBS Aqua dest.
CPS 20 42 80 0.09
CPS 40 86 127 0.138
CPS 100 159 173 0.04
CPS 200 245 320 0.145
AMI 20 21 54 0.495
CNT8 4581 26 1.00
CNT20 1140 38 0.597
CNT50 885 50 0.449the VITROCELL/PARI BOY system was 0.038 ± 0.0068% for the
20 nm FluoSpheres and 0.029 ± 0.0073% for larger (40–200 nm)
FluoSpheres (Fig. 4a). The total deposition rate in the VITROCELL/
PARI BOY system was 6.3 times higher for the ﬂuorescein reference
compared with the 20 nm FluoSpheres and 7.9 times higher com-
pared with the larger FluoSpheres (p < 0.001, Fig. 4a). The differ-
ences in deposition rate between small and large nanoparticles
were not signiﬁcant. CNTs show signiﬁcantly higher deposition
rates between 8.81 ± 0.92% for CNT8 and 1.25 ± 0.07% for CNT50
(Fig. 4b).
The deposition rate with the MicroSprayer showed minimal
variation between the reference substance and FluoSpheres of all
sizes: ﬂuorescein was deposited with an efﬁcacy of 27 ± 3%, Fluo-
Spheres with an efﬁcacy of 28 ± 1.96% and CNTs with an efﬁcacy
of 25 ± 2.5%.
Signiﬁcant differences in the distribution rate among the three
VITROCELL/PARI BOY compartments were noted for both nanopar-
ticles and ﬂuorescein but the differences were larger for the poly-
styrene particle-containing aerosols (55%, 31%, 14%) compared
with the reference substance (39%, 32%, 29%). No signiﬁcant differ-
ence in the distribution among the compartments was seen for the
tested CNTs.
3.4. Cytotoxicity testing with the MicroSprayer
Cytotoxicity testing was performed with the MicroSprayer,
where higher concentrations could be applied. Cytotoxicity of
aerosolized amine-functionalized polystyrene in ALI cultured cells
at all doses was signiﬁcantly higher than that of nanoparticle sus-
pensions in submersed cells (Fig. 5, p < 0.05). Signiﬁcant cytotoxic-
ity was detected as low as a 31 lg/cm2 of aerosolized nanoparticles
in ALI cultures. In submersed (LCC) culture exposed to a nanopar-
ticle suspension a signiﬁcant cytotoxic effect was detected only at
a concentration of 62 lg/cm2 (Fig. 5, p < 0.05). At 62 lg/cm2 TEER
values were signiﬁcantly decreased and staining against ZO-1
showed a diffuse cytoplasmic pattern. For CPS 20 and CNT8 no sig-
niﬁcant reduction in viability at the maximum concentration,
which could be applied, was seen. The other CPS and CNTs were
not evaluated for cytotoxicity because they were less toxic in sub-
mersed culture than CPS 20 and CNT8.4. Discussion
In this study, A549 cells cultured in ALI were exposed to aero-
sols for a more physiological testing of therapeutic nanoparticle
containing aerosols. In this culture system the use of a new combi-
nation of test systems (VITROCELL + PARI BOY) was compared to a
manual aerosol generating system, the MicroSprayer. PARI LC
SPRINT nebulizers are commonly used for inhalation treatment
by patients and the aerosol composition used in our study is there-
fore similar to that inhaled by patients. With both aerosol-generat-e (AMI) functionalized polystyrene particles and carbon nanotubes (CNTs). Mean from
rface charge) is given.
ity index f-Potential (mV)
DMEM, 10% FBS Aqua dest. DMEM, 10% FBS
0.157 44.9 8.3
0.20 34.6 11.6
0.21 41.2 9.6
0.57 46.6 11.9
0.384 40.1 9.2
0.545 15.6 0.64
0.34 10.7 8.47
0.442 16.9 11.0
Fig. 2. Physiological and morphological characterization of not exposed A549 cells cultured in air–liquid interface (ALI) culture. (a): Development of the transepithelial
electrical resistance (TEER) in A549 cells cultured in transwells. Means ± SD of n = 5 experiments are given. (b–e): Immunocytochemical detection of tight junction proteins
after 7 days in ALI culture: Claudin-1 (red, b), ZO-1 (green, c) and E-cadherin (red, d) is seen between A549 cells cultured on transwells. Co-labeling of ZO-1 with E-cadherin
(e) shows that the proteins are localized in different membrane areas. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web
version of this article.)
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to cells was limited and concentration, where cytotoxicity was ex-
pected based on conventional testing in suspensions, were only
reached for amine-functionalized polystyrene particles. With these
particles a signiﬁcantly higher cytotoxicity was seen upon aerosol
exposure than when applying nanoparticles in suspension.
The VITROCELL/PARI BOY system presented in this study al-
lowed testing of nanoparticle based aerosols in a physiological
exposure and without causing cell damage by the exposure system
itself. The deposition rates of 0.175% for the reference substance
and a maximum of 0.037% for aerosolized polystyrene particles
in the VITROCELL/PARI BOY system are, however, lower than those
of other existing systems. For instance, using the ALICE system
(Lenz et al., 2009) for in vitro exposure 7.2% of the dose were deliv-
ered to an area of two 6-well plates (215.9 cm2). Cells cultured inan insert, therefore, would receive 0.157% of the total nebulized
nanoparticle dose. Using a nose-only inhalation in mice only
0.008% of the nebulized dose reached the lung (Nadithe et al.,
2003). Even upon instillation into the lung at the bifurcation of
the trachea only 5% of the aerosol reaches the lung periphery
where absorption can take place. In rabbits with tracheostoma, a
model for the neonatal lung, deposition by nebulizers has been re-
ported between 0.05% and 1.96% (Cameron et al., 1991; Flavin
et al., 1986). Regarding the deposition rate of polystyrene particles,
the MicroSprayer is much more efﬁcient because the delivery rate
is more than 700 times higher than the VITROCELL/PARI BOY sys-
tem. For the assessment of conventional substances and polysty-
rene particles the VITROCELL/PARI BOY system also has the
disadvantage that the deposition rate is not the same for all com-
partments of the system. The observed decrease in the deposition
Fig. 3. Distribution of ﬂuorescently labeled (red) carboxyl-functionalized polystyrene particles (FluoSpheres, FS) on A549 cells 24 h after exposure in the VITROCELL6 PT-CF/
PARI BOY system. Cells are stained by phalloidin (green) and counterstained with Hoechst 33342 (blue). (For interpretation of the references to colour in this ﬁgure legend,
the reader is referred to the web version of this article.)
Table 2
Overview on deposition rate maximum applied concentration and cytotoxic effect at that concentration in air–liquid interface culture (ALI) and in submersed culture (LCC) of
carboxyl (CPS) and amine (AMI) functionalized polystyrene particles and carbon nanotubes (CNTs).
Exposure VitroCell MicroSprayer
Deposition (%,
n = 3) 1st–3rd
compartment
Maximum
concentration
(lg/cm2)
Viability at maximum
concentration (%,
mean ± SD, n = 3), ALIa
Deposition
(%,
mean ± SD,
n = 4)
Maximum
concentration
(lg/cm2)
Viability at maximum
concentration (%,
mean ± SD, n = 4), ALI
Viability at maximum
concentration (%,
mean ± SD, n = 4), LCC
Air n.a. n.a. 85 ± 8 n.a. n.a. 85 ± 8 n.a.
Solvent n.a. n.a. 110 ± 10 n.a. n.a. 112 ± 7 100
CPS 20 0.011–0.038 0.0007 98 ± 7 28 ± 1.96 148.67 98 ± 8 100 ± 7
CPS 40 0.012–0.036 0.0006 n.d. 28 ± 1.97 148.67 n.d 108 ± 1
CPS 100 0.009–0.032 0.0006 n.d. 28 ± 1.98 148.67 n.d 113 ± 4
CPS 200 0.003–0.021 0.0004 n.d. 28 ± 1.99 148.67 n.d 104 ± 1
AMI 20 n.a.b 0.0007 95 ± 8 n.a.b 89.07 2 ± 2 78.5 ± 3
CNT8 6.4–6.81 0.0241 99 ± 12 25 ± 2.5 66.37 93 ± 6 103 ± 2
CNT20 4.04–4.66 0.0165 n.d. 25 ± 2.5 66.37 n.d 97 ± 5
CNT50 0.81–1.66 0.0059 n.d. 25 ± 2.5 66.37 n.d 97 ± 12
Abbreviations: n.a., not applicable; n.d., not determined.
a No LCC data are given because at all concentrations no cytotoxic effect is expected.
b Determination not possible because the particles are not colored and not ﬂuorescent.
E. Fröhlich et al. / Toxicology in Vitro 27 (2013) 409–417 415rate from the 1st to the 3rd compartment appears to be inherent to
the system but affects aerosolized conventional substances and
nanoparticles to different degrees. Taking the low absolute deposi-
tion rates of the polystyrene particles in this system and the sensi-
tivity of the ﬂuorescence plate reader into account, the signiﬁcance
and the relevance of the observed differences could, however, be
questioned. For the evaluation of CNTs the differences between
VITROCELL/PARI BOY system and MicroSprayer were less pro-
nounced; the distribution between the compartments of the
VITROCELL/PARI BOY was more homogeneous and the Micros-
prayer delivered only about 4 times more CNTs to the wells. CNTs
have a much higher tendency to form aggregates (Lee et al., 2007)
and, therefore, may form aggregates of appropriate size for sedi-
mentation on the cells. The MicroSprayer delivers more aerosol-
ized nanoparticles to the cells than the VITROCELL/PARI BOY
system, which is important for cytotoxicity testing. On the other
hand application with the MicroSprayer might damage cells bygeneration of shear stress because high ﬂow rates are needed for
effective particle deposition. Decreases in cell viability due to
impaction of aerosols have been shown by Mühlhopt et al. (Mülh-
opt et al., 2007). Although adverse effects on cells cannot be ex-
cluded this study do not provide any indication for cell damage
by using the MicroSprayer.
Both aerosol generating systems were assessed with respect to
cytotoxicity testing. This assessment is an important ﬁrst step in
the toxicological assessment of compounds. Routine cytotoxicity
testing, the exposure by addition of the test compounds to the
medium above cells seeded in plastic wells (submersed culture),
is not physiological for respiratory cells. It may lead to a sub-esti-
mation of their cytotoxicity because a direct contact of the nano-
particles with the plasma membrane is not likely. Therefore, cells
cultured in ALI and exposed to aerosols are recommended for
physiologically relevant in vitro testing. This recommendation is
supported by data showing the higher induction of the anti-oxida-
Fig. 4. Deposition rate (% of nanoparticles in the respective compartment referred to total aerosolized nanoparticles) and distribution rate (% of nanoparticles in the
respective compartment normalized to the total amount deposited) of ﬂuorescein, ﬂuorescently-labeled 20 nm and larger (40–200 nm) carboxyl-functionalized polystyrene
particles (FluoSpheres, FS, a) and carbon nanotubes of <8 nm (CNT8), 20–30 nm (CNT20) and >50 nm (CNT50, b) in the VITROCELL6 PT-CF/PARI BOY system. Data are
presented as means ± SD of n = 3 experiments. The three chambers of the VITROCELL6 PT-CF exposure unit are termed as 1st, 2nd, and 3rd compartment. Signiﬁcant
differences in the deposition and distribution of the respective compartment to the 1st compartment are indicated by an asterisk and signiﬁcant differences to the respective
values in the 2nd compartment by a hash (p < 0.05).
Fig. 5. Cytotoxicity of amine-functionalized polystyrene particles in A549 cells
assessed by the MTS assay. The particles were tested either in suspension on
submersed culture (liquid culture, LCC) or as aerosol on ALI cultures with the
MicroSprayer. Concentrations are indicated as lg/cm2 and are based on a
deposition rate of 29% as determined in previous experiments. Viability of solvent
exposed cells is set as 100%. Data are presented as means ± SD of n = 4 experiments
and signiﬁcant differences (p < 0.05) are indicated by an asterisk.
416 E. Fröhlich et al. / Toxicology in Vitro 27 (2013) 409–417tive enzyme HO-1 in A549 upon exposure to ZnO nanoparticles in
ALI than in submersed culture (Lenz et al., 2009). The higher cyto-
toxicity of aerosolized polystyrene nanoparticles reported in this
study also suggests a stronger effect upon aerosol application. It
may be suspected that for nanoparticles with a greater tendency
for aggregation, like CNTs, the exposure condition (aerosol or sus-
pension) has a much smaller inﬂuence on the cytotoxicity.
For cytotoxicity testing, where high concentrations have to be
tested to determine safety margins, the use of the MicroSprayerappears indicated because much higher doses than with the
VITROCELL/PARI BOY system can be applied and the application it-
self did not cause adverse effects on cells. These data together with
data from other groups (Fiegel et al., 2003; Knebel et al., 2001; Savi
et al., 2008) show that higher aerosol delivery rates can only be ob-
tained by a less physiological application mode. To assess the efﬁ-
cacy of aerosolized nanoparticles at therapeutic doses the
VITROCELL/PARI BOY system appears better because it mimics bet-
ter the low ﬂow velocities in the alveoli. Providing every compart-
ment with one nebulizer could decrease the differences in the
deposition rates between the compartments.Acknowledgments
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